Multiplex determination of serological signatures in the sera of colorectal cancer patients using hydrogel biochips

Colorectal cancer (CRC) is the third most common malignancy in industrialized countries. Despite the advances in diagnostics and development of new drugs, the 5‐year survival remains only 60–65%. Our approach to early diagnostics of CRC is based on the determination of serological signatures with an...

Descripción completa

Detalles Bibliográficos
Autores principales: Butvilovskaya, Veronika I., Popletaeva, Sofya B., Chechetkin, Vladimir R., Zubtsova, Zhanna I., Tsybulskaya, Marya V., Samokhina, Larisa O., Vinnitskii, Leonid I., Ragimov, Aligeydar A., Pozharitskaya, Elena I., Grigor´eva, Galina A., Meshalkina, Natalya Y., Golysheva, Svetlana V., Shilova, Nadezhda V., Bovin, Nicolai V., Zasedatelev, Aleksander S., Rubina, Alla Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944861/
https://www.ncbi.nlm.nih.gov/pubmed/26992329
http://dx.doi.org/10.1002/cam4.692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944861/
https://www.ncbi.nlm.nih.gov/pubmed/26992329
http://dx.doi.org/10.1002/cam4.692

Ejemplares similares